We found that the combined HR (1.40) for the GBM data alone was larger than that for all 6 eligible studies of glioma (1.30), suggesting that PD-L1 expression could serve as an important prognostic factor for malignant glioma. This evidence concerns the gene CD274 and central nervous system cancer.